ALAHIST CF- dexbrompheniramine maleate, dextromethorphan hbr, phenylephrine hcl tablet 
Poly Pharmaceuticals, Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Alahist CF Tablets

ACTIVE INGREDIENT

Active Ingredient (in each tablet) Purpose

Dexbrompheniramine Maleate 2 mg​

Antihistamine
Dextromethorphan Hydrobromide 20 mgCough Supressant
Phenylephrine HCl 10mgNasal Decongestant

USES

Temporarily relieves these symptoms due to the
common cold, hay fever (allergic rhinitis) or other
upper respiratory allergies:

WARNINGS

Do not exceed recommended dosage.

Do not use this product
if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or
emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.

Ask a doctor before use ifyou have

Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers.

When using this product

Stop use and ask a doctor if
 nervousness, dizziness, or sleeplessness occur
 symptoms do not improve within 7 days or are accompanied by fever

If pregnant or breast-feeding, ask a health
professional before use.

DIRECTIONS

Directions

Adults and children 12 years of age and over1 tablet every 4 to 6 hours, not to exceed 6 tablets in 24 hours
Children 6 to under 12 years of age1/2 tablet every 4 to 6 hours, not to exceed 3 tablets in 24 hours

INACTIVE INGREDIENTS

Inactive ingredients
Croscarmellose Sodium, Magnesium Stearate, Microcrystalline Cellulose, Natural Yellow, Pregelatinized Starch, Silicon Dioxide

QUESTIONS

Questions? Comments?
Call 1-800-882-1041
Manufactured for:
Poly Pharmaceuticals
Huntsville, AL 35763 Rev. 04/17

OTHER INFORMATION

Other information
Store at 15°-30°C (59°-86°F). Supplied in a tight, light-resistant container with a child-resistant cap. Alahist CF Tablets are light yellow,caplet-shaped, scored tablets, debossed "C" bisect "F" on one side and plain on the other.

​Keep out of reach of children

​In case of overdose, get medical help or contact a Poison Control Center right away.

Antihistamine

Cough Suppressant

Nasal Decongestant

ALAHISTlabellabelbooklet

ALAHIST CF 
dexbrompheniramine maleate, dextromethorphan hbr, phenylephrine hcl tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:50991-784
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
DEXBROMPHENIRAMINE MALEATE (UNII: BPA9UT29BS) (DEXBROMPHENIRAMINE - UNII:75T64B71RP) DEXBROMPHENIRAMINE MALEATE2 g
DEXTROMETHORPHAN HYDROBROMIDE (UNII: 9D2RTI9KYH) (DEXTROMETHORPHAN - UNII:7355X3ROTS) DEXTROMETHORPHAN HYDROBROMIDE20 g
PHENYLEPHRINE HYDROCHLORIDE (UNII: 04JA59TNSJ) (PHENYLEPHRINE - UNII:1WS297W6MV) PHENYLEPHRINE HYDROCHLORIDE10 g
Inactive Ingredients
Ingredient NameStrength
DEXTROSE (UNII: IY9XDZ35W2)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
STARCH, PREGELATINIZED CORN (UNII: O8232NY3SJ)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
TURMERIC (UNII: 856YO1Z64F)  
Product Characteristics
ColoryellowScore2 pieces
ShapeOVALSize11mm
FlavorImprint Code C;F
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:50991-784-9090 in 1 BOTTLE; Type 0: Not a Combination Product09/14/2017
2NDC:50991-784-0212 in 1 BLISTER PACK; Type 0: Not a Combination Product09/14/2017
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart34109/14/2017
Labeler - Poly Pharmaceuticals, Inc. (198449894)
Establishment
NameAddressID/FEIBusiness Operations
Monarch PCM, LLC080000294manufacture(50991-784)
Establishment
NameAddressID/FEIBusiness Operations
Rainbow Gold Products, Inc800695152repack(50991-784)

Revised: 1/2020
Document Id: 9c9f47b5-910a-71a4-e053-2995a90ac59d
Set id: 59774c8a-deaf-53a6-e053-2991aa0a709f
Version: 2
Effective Time: 20200120
 
Poly Pharmaceuticals, Inc.